Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proellex® Pharmacokinetic Bridging Study II

NCT00620503 is registered in ClinicalTrials.gov with Repros Therapeutics Inc. as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00620503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Proellex® Pharmacokinetic Bridging Study II
Lead sponsor
Repros Therapeutics Inc.
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2008
Completion date
April 30, 2008
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy